Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00096005
First received: November 9, 2004
Last updated: February 21, 2014
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)